418 related articles for article (PubMed ID: 25952368)
1. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
2. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q
Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
[TBL] [Abstract][Full Text] [Related]
3. Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study.
Ren H; Wu C; Shao Y; Liu S; Zhou Y; Wang Q
Front Med; 2020 Oct; 14(5):642-650. PubMed ID: 31950345
[TBL] [Abstract][Full Text] [Related]
4. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of hypoxia inducible Factor-1α in patients with diabetic nephropathy.
Wang J; Ye S
Niger J Clin Pract; 2019 Jun; 22(6):750-753. PubMed ID: 31187757
[TBL] [Abstract][Full Text] [Related]
6. The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio.
Ma X; Lu C; Lv C; Wu C; Wang Q
J Diabetes Res; 2016; 2016():6789402. PubMed ID: 26881255
[TBL] [Abstract][Full Text] [Related]
7. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
Shao Y; Lv C; Yuan Q; Wang Q
J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
[TBL] [Abstract][Full Text] [Related]
8. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
Zhai Y; Cao X; Liu S; Shen Y
Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
[TBL] [Abstract][Full Text] [Related]
10. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract.
Lai X; Tong D; Ai X; Wu J; Luo Y; Zuo F; Wei Z; Li Y; Huang W; Wang W; Jiang Q; Meng X; Zeng Y; Wang P
Sci Rep; 2018 Nov; 8(1):16707. PubMed ID: 30420600
[TBL] [Abstract][Full Text] [Related]
12. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
[TBL] [Abstract][Full Text] [Related]
13. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.
Ibrahim S; Rashed L
Saudi Med J; 2007 Apr; 28(4):519-23. PubMed ID: 17457470
[TBL] [Abstract][Full Text] [Related]
14. MiR-130b increases fibrosis of HMC cells by regulating the TGF-β1 pathway in diabetic nephropathy.
Ma Y; Shi J; Wang F; Li S; Wang J; Zhu C; Li L; Lu H; Li C; Yan J; Zhang X; Jiang H
J Cell Biochem; 2019 Mar; 120(3):4044-4056. PubMed ID: 30260005
[TBL] [Abstract][Full Text] [Related]
15. Potential serum biomarkers for early detection of diabetic nephropathy.
Motawi TK; Shehata NI; ElNokeety MM; El-Emady YF
Diabetes Res Clin Pract; 2018 Feb; 136():150-158. PubMed ID: 29253627
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
Khan S; Qayyum S; Khan MNA
J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
[TBL] [Abstract][Full Text] [Related]
17. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
[TBL] [Abstract][Full Text] [Related]
18. Endocan and albuminuria in type 2 diabetes mellitus.
Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
[TBL] [Abstract][Full Text] [Related]
19. New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.
Eroglu İ; Korkmaz H; Ozturk KH; Sirin FB; Sevik S; Afsar B
Minerva Endocrinol (Torino); 2022 Sep; 47(3):314-324. PubMed ID: 33331738
[TBL] [Abstract][Full Text] [Related]
20. Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy.
Yu H; Wang H; Su X; Cao A; Yao X; Wang Y; Zhu B; Wang H; Fang J
BMC Nephrol; 2022 Jan; 23(1):41. PubMed ID: 35062888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]